SCHEMBL580820

SCHEMBL580820

CCOC(=O)CCOCCO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
CYP4F2 P78329 4/20 0.47
CYP4A11 Q02928 4/20 0.47
CYP1A2 P05177 1/20 0.47
GAA P10253 2/20 0.46
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
TSHR P16473 2/20 0.43
MAPK1 P28482 1/20 0.43
TRPA1 O75762 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
THRB P10828 1/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.39
EPHX2 P34913 1/20 0.38
NR1I2 O75469 1/20 0.38
PGR P06401 1/20 0.38
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18095349 0.98 ALDH1A1 (0.46) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
SCHEMBL19666694 0.98 ALDH1A1 (0.46) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
Di(Hydroxyethyl)Ether SCHEMBL28213240 0.91 GAA (0.52) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
SCHEMBL6817948 0.91 GAA (0.55) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
Di(Hydroxyethyl)Ether SCHEMBL3340420 0.89 TSHR (0.46) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
SCHEMBL1727365 0.89 GAA (0.52) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
SCHEMBL13754179 0.89 GAA (0.52) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
Tetraethylene Glycol SCHEMBL3342135 0.88 MEN1 (0.45) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
Triethylene Glycol SCHEMBL3339555 0.88 MEN1 (0.45) ALDH1A1CYP4F2CYP4A11CYP1A2GAA
SCHEMBL28264595 0.88 CYP4F2 (0.49) ALDH1A1CYP4F2CYP4A11CYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12216403-B2 Positive photosensitive resin composition and display device using the same DONJIN SEMICHEM CO., LTD. (KR) 2025-02-04 US claimed
US-20240118616-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND DISPLAY DEVICE USING THE SAME DONGJIN SEMICHEM CO., LTD. (KR) 2024-04-11 US claimed
US-7950794-B2 Solvent based inkjet ink formulation KIIAN S.P.A. (IT) 2011-05-31 US claimed
US-20070263018-A1 Solvent Based Inkjet Ink Formulation LECHLER S.P.A. (IT) 2007-11-15 US claimed
EP-1749070-A1 SOLVENT BASED INKJET INK FORMULATION Lechler S.p.A. (IT) 2007-02-07 EP claimed
WO-2005116149-A1 SOLVENT BASED INKJET INK FORMULATION LECHLER S.P.A. (IT) 2005-12-08 WO claimed
US-5122603-A PURIFIED INSULIN MEDIATORS AND PURIFICATION PROCESS FOR SAME THE UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1992-06-16 US claimed
US-12577401-B2 Curable resin composition, cured film formed therefrom, and electronic device having cured film SAMSUNG SDI CO., LTD. (KR) 2026-03-17 US disclosed
WO-2025034849-A1 FUSED PYRIDAZINES FOR THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2025-02-13 WO disclosed
US-12216403-B2 Positive photosensitive resin composition and display device using the same DONJIN SEMICHEM CO., LTD. (KR) 2025-02-04 US disclosed
EP-4452945-A2 CHEMICAL LINKERS Sigma-Aldrich Co. LLC (US) 2024-10-30 EP disclosed
US-20240118616-A1 POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND DISPLAY DEVICE USING THE SAME DONGJIN SEMICHEM CO., LTD. (KR) 2024-04-11 US disclosed
US-20230279230-A1 CURABLE RESIN COMPOSITION, CURED FILM FORMED THEREFROM, AND ELECTRONIC DEVICE HAVING CURED FILM SAMSUNG SDI CO., LTD. (KR) 2023-09-07 US disclosed
US-5733932-A VIRICIDES MARKING AND BLOCKING SPECIFIC VIRAL PROTEINS THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1998-03-31 US disclosed
US-5703086-A TREATMENT OF HIV INFECTIONS THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1997-12-30 US disclosed
US-5620983-A BLOCKING MOVEMENT OF VIRAL GENOME PARTICLES THROUGH NUCLEAR MEMBRANE IN TERMINALLY DIFFERENTIATED CELLS TO PREVENT VIRAL INFECTIONS THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1997-04-15 US disclosed
US-5574040-A DIALKANOYLPHENYLPYRIMIDINE DERIVATIVES PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1996-11-12 US disclosed
WO-1996020932-A1 COMPOUNDS AND METHODS OF USE TO TREAT INFECTIOUS DISEASES THE PICOWER INSTITUTE FOR MEDICAL RESEARCH (US) 1996-07-11 WO disclosed
EP-0611049-A1 Method of lubricating an elastic fibrous material THE DOW CHEMICAL COMPANY (US) 1994-08-17 EP disclosed
US-4022808-A ZINC-ALUMINUM-TITANIUM-TIN-IRON OR GROUP 5A AS CATALYSTS NIPPON SODA COMPANY LIMITED (JA) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577401-B2 Curable resin composition, cured film formed therefrom, and electronic device having cured film SEM1, CARM1, CAD ALDH1A1 1948/4885CYP4F2 863/4885CYP4A11 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.